Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Hepagene Therapeutics

    Client Virtual Booth

    HEPAGENE THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Hepagene Therapeutics
    China Flag
    Country
    Country
    China
    Address
    Address
    4560 Jin Ke Road, Building 1, 5th Floor Pudong District, Shanghai 201210
    Telephone
    Telephone
    021-61215841
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.hepagene.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Hepagene Announces FDA Clearance of IND for HPG7233 THR Beta Agonist
    Hepagene Announces FDA Clearance of IND for HPG7233 THR Beta Agonist

    https://www.prnewswire.com/news-releases/hepagene-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-ind-for-hpg7233-thr-beta-agonist-301933223.html

    PR NEWSWIRE
    20 Sep 2023
    Share Share
    Hepagene Therapeutics to Present at the EASL Congress 2023
    Hepagene Therapeutics to Present at the EASL Congress 2023

    https://www.prnewswire.com/news-releases/hepagene-therapeutics-to-present-at-the-european-association-for-the-study-of-the-liver-easl-congress-2023-301834650.html

    PR NEWSWIRE
    25 May 2023
    Share Share
    Hepagene Therapeutics Initiates the RISE Study, a Phase IIa Clinical Trial of HPG1860 in Patients with NASH
    Hepagene Therapeutics Initiates the RISE Study, a Phase IIa Clinical Trial of HPG1860 in Patients with NASH

    https://www.pharmacompass.com/pdf/news/hepagene-therapeutics-initiates-the-rise-study-a-phase-iia-clinical-trial-of-hpg1860-in-patients-with-nash-1641805439.pdf

    PRESS RELEASE
    02 Dec 2021
    Share Share
    Hepagene Initiates the RISE Study, of HPG1860 in Patients with NASH
    Hepagene Initiates the RISE Study, of HPG1860 in Patients with NASH

    https://www.prnewswire.com/news-releases/hepagene-therapeutics-initiates-the-rise-study-a-phase-iia-clinical-trial-of-hpg1860-in-patients-with-nash-301434639.html

    PRNEWSWIRE
    02 Dec 2021
    Share Share
    Hepagene Therapeutics Announces Positive Results from Phase I Trial of HPG1860
    Hepagene Therapeutics Announces Positive Results from Phase I Trial of HPG1860

    https://www.prnewswire.com/news-releases/hepagene-therapeutics-inc-announces-positive-results-from-phase-i-trial-of-hpg1860-301359762.html

    PRNEWSWIRE
    23 Aug 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search